Literature DB >> 27671508

Regulatory T Cells and Myeloid-Derived Suppressor Cells in Patients with Peptic Ulcer and Gastric Cancer.

Hamideh Mesali1, Abolghasem Ajami, Hadi Hussein-Nattaj, Alireza Rafiei, Zeinab Rajabian, Hossein Asgarian-Omran, Vahid Hosseini, Tarang Taghvaei, Mohsen Tehrani.   

Abstract

BACKGROUND: Regulatory T Cells (Tregs) and Myeloid-Derived Suppressor Cells (MDSCs) are two main regulatory cells modulating the immune responses in inflammation and cancer.
OBJECTIVE: To investigate and compare Tregs and MDSCs in peptic ulcer and gastric cancer.
METHODS: Patients with dyspepsia were selected and divided into three groups of non-ulcer dyspepsia (NUD, n=22), peptic ulcer disease (PUD, n=25), and gastric cancer (GC, n=27) according to their endoscopic and histopathological examinations. Helicobacter pylori infection was diagnosed by rapid urease test and histopathology. The number of peripheral blood CD4+CD25+FoxP3+Tregs and CD14+HLA-DR- MDSCs were determined in all patients, by flow cytometry. The number of FoxP3+ regulatory T cells was also determined by immunohistochemistry (IHC).
RESULTS: The percentage of peripheral blood Treg cells in both PUD (0.81 ± 0.39, p<0.001) and GC groups (0.98 ± 0.65, p<0.001) were significantly higher than in NUD group (0.46 ± 0.10). These results were also confirmed by IHC. A significantly higher percentage of MDSCs in patients with PUD (0.73 ± 0.19, p<0.001) and GC (0.73 ± 0.16, p<0.001) was also observed when compared to NUD group (0.46 ± 0.16). There was no difference in the percentages of these two cell types between the PUD and GC groups. The percentages of Tregs and MDSCs in patients with PUD and GC were not significantly correlated.
CONCLUSIONS: Both Tregs and MDSCs showed higher frequencies in PUD and GC. These results suggest that immune-modulation by the Tregs and MDSCs may play a role in the pathogenesis of PUD and GC.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27671508     DOI: IJIv13i3A2

Source DB:  PubMed          Journal:  Iran J Immunol        ISSN: 1735-1383            Impact factor:   1.603


  5 in total

Review 1.  NF-kappaB: Two Sides of the Same Coin.

Authors:  Bruno R B Pires; Rafael C M C Silva; Gerson M Ferreira; Eliana Abdelhay
Journal:  Genes (Basel)       Date:  2018-01-09       Impact factor: 4.096

2.  The safety of influenza vaccine in clinically cured leprosy patients in China.

Authors:  Yi Zheng; Li Chen; Jie Zou; Zheng-Gang Zhu; Li Zhu; Jing Wan; Quan Hu
Journal:  Hum Vaccin Immunother       Date:  2017-12-14       Impact factor: 3.452

Review 3.  Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics.

Authors:  Mitesh Dwivedi; Sanjay Tiwari; E Helen Kemp; Rasheedunnisa Begum
Journal:  Heliyon       Date:  2022-08-27

Review 4.  Therapeutic strategies for gastric cancer targeting immune cells: Future directions.

Authors:  Yan Zhao; Yuansong Bai; Meili Shen; Yapeng Li
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

5.  Circulating and tumor-infiltrating arginase 1-expressing cells in gastric adenocarcinoma patients were mainly immature and monocytic Myeloid-derived suppressor cells.

Authors:  WeiHong Ren; XuRan Zhang; WenBo Li; Qian Feng; HuiJie Feng; Yan Tong; Hao Rong; Wei Wang; Dai Zhang; ZhenQiang Zhang; ShiChun Tu
Journal:  Sci Rep       Date:  2020-05-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.